Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteers

British Journal of Clinical Pharmacology

Volumn 52, Issue 6, 2001, Pages 705-707

  Kees, F ^a   Farber L ^a   Bucher, M ^a   Mair, G ^b   Morike K ^c   Grobecker, H ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Intensive Care Unit   (Germany)

^c DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

Bioavailability; Low doses; Tropisetron; Volunteers

Indexed keywords

CYTOCHROME P450 2D6; ORAL CONTRACEPTIVE AGENT; SPARTEINE; TROPISETRON;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; ANTIEMETICS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; CYTOCHROME P-450 CYP2D6; FEMALE; HALF-LIFE; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; SPARTEINE;

EID: 0035672931     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01512.x     Document Type: Article

References (6)

1. Tropisetron. An update of its use in the prevention of chemotherapy-induced nausea and vomiting
2. Tropisetron. A review of the clinical experience
3. 3 receptor antagonist
4. The genetic polymorphism of sparteine metabolism
5. Determination of opipramol in human plasma by high-performance liquid chromatography with photometric detection using a cyanopropyl column